Functional Skills
Procurement
Strategic Planning
Crisis Management
Business Continuity
Agile Software Development
Data Analysis
Business Development
Quality Management
Quality Assurance
Financial Modeling
Biostatistics
Operational Efficiency
Good Manufacturing Practice (GMP)
Pricing Strategy
Market Access Strategy
Software Skills
Asana
Jira
PowerBI
Stata
Scheme
Sector Experience
Business Services
Financial Services
Healthcare
Life Sciences & Pharma
Social & Public Sector
Experience
The Rosslyn Group
Corporate Strategy & Development
Independent Senior Consultant
2/2025 - Present
Washington, DC
● • Led business development strategies for sovereign and corporate clients, including countries in Eastern Europe, the Middle East, and Africa, for advisory on geopolitical strategies and engagement with the executive branch and the US Congress, regarding DOGE impacts on existing bilateral agreements on foreign assistance and trade.
● • Led business development strategies for sovereign and corporate clients, including countries in Eastern Europe, the Middle East, and Africa, for advisory on geopolitical strategies and engagement with the executive branch and the US Congress, regarding DOGE impacts on existing bilateral agreements on foreign assistance and trade.
USAID'S CRITICAL
Management Consulting
Senior Strategy and Budget Lead
3/2024 - 2/2025
• Spearheaded USAID's Operational Readiness Strategy ), aligning with Federal Continuity Directive 1
● to enhance agency-wide operational resilience during future crises. Worked closely with M/CCS teams, B/IO leadership in Washington, and with Mission leadership on the formulation and implementation of agency policy and guidance on crisis resilience.
• Reviewed USAID Enterprise Risk Management(ERM) program to ensure the agency's risk profile aligns with the Agency's operational readiness postures.
• Updated the USAID Pandemic Preparedness Plan, institutionalizing COVID-19 response protocols on workforce vaccination, supply chains, remote work, devolution, and other capabilities.
• Developed ADS 530 policy for Foreign Service Nationals' emergency preparedness, engaging across 87 USAID Missions in Africa, Asia, Eurasia and Europe, Latin America and Caribbean, and Middle East, including engagement with the global FSN community, FSN Advocacy Council, Mission FSN Committees, in country
● to enhance agency-wide operational resilience during future crises. Worked closely with M/CCS teams, B/IO leadership in Washington, and with Mission leadership on the formulation and implementation of agency policy and guidance on crisis resilience.
• Reviewed USAID Enterprise Risk Management(ERM) program to ensure the agency's risk profile aligns with the Agency's operational readiness postures.
• Updated the USAID Pandemic Preparedness Plan, institutionalizing COVID-19 response protocols on workforce vaccination, supply chains, remote work, devolution, and other capabilities.
• Developed ADS 530 policy for Foreign Service Nationals' emergency preparedness, engaging across 87 USAID Missions in Africa, Asia, Eurasia and Europe, Latin America and Caribbean, and Middle East, including engagement with the global FSN community, FSN Advocacy Council, Mission FSN Committees, in country
Oppenheimer & Co.
Finance
Independent Senior Consultant, Debt Capital Markets & Syndication
9/2018 - 3/2024
• Led a $300M blended finance initiative for regional pharmaceutical manufacturing in Africa, conducting health economic analyses, sector growth and sustainability planning, relevant to shifting production from APAC countries to Africa, engaging APAC and African finance ministers for contributions to the facility.
• Collaborated with cross-functional teams to develop value propositions and market access playbooks for Eurobond issuances and other fixed income products, engaging presidential offices and finance ministers, supporting healthcare infrastructure investments during the COVID-19 pandemic.
• Conducted competitive landscape analyses to position financial products against concessional financing, ensuring compliance with IMF frameworks and other Brentwood agreements.
• Facilitated a $60M financing facility for a Kenyan oncology center, including bankability and coupon pricing analyses, with transferable skills for EMEA market development.
• Originated projects and structured c
• Collaborated with cross-functional teams to develop value propositions and market access playbooks for Eurobond issuances and other fixed income products, engaging presidential offices and finance ministers, supporting healthcare infrastructure investments during the COVID-19 pandemic.
• Conducted competitive landscape analyses to position financial products against concessional financing, ensuring compliance with IMF frameworks and other Brentwood agreements.
• Facilitated a $60M financing facility for a Kenyan oncology center, including bankability and coupon pricing analyses, with transferable skills for EMEA market development.
• Originated projects and structured c
JLM FOUNDATION
Corporate Strategy & Development
Director | Senior Advisor
10/2016 - 2/2024
• Designed market access strategies for HIV diagnostic and treatment commodities, collaborating with APAC stakeholders like the China Chamber of Commerce for Medicines and Health Products Import and Export, aligning APAC supply chains with African markets' regulatory and reimbursement requirements, and securing product coding on federal and the Global Fund pooled procurement contracts.
• Led the design of market access and payer strategy for HIV generic drugs and chronic disease drugs targeted for local pharmaceutical production in Africa, including market segmentation and targeting strategies based on Senior Strategic Planner Global Market Access Global Health Economics Portfolio Management Washington, DC
● competitive landscape analysis across African markets. Developed value-based pricing strategies for generic drugs for DOS/PEPFAR as the prime buyer, to inform the value proposition for local production.
• Developed advocacy frameworks to promote a blended Finance facility veh
• Led the design of market access and payer strategy for HIV generic drugs and chronic disease drugs targeted for local pharmaceutical production in Africa, including market segmentation and targeting strategies based on Senior Strategic Planner Global Market Access Global Health Economics Portfolio Management Washington, DC
● competitive landscape analysis across African markets. Developed value-based pricing strategies for generic drugs for DOS/PEPFAR as the prime buyer, to inform the value proposition for local production.
• Developed advocacy frameworks to promote a blended Finance facility veh
US CDC
Research
Fellowship
5/2022 - 8/2022
Washington, DC
● • Supported evaluation of Early Infant Diagnosis programs in Cameroon and Uganda, drafting of evaluation protocols in collaboration with CDC Atlanta staff and PEPFAR in-country teams, and performed data analysis, reporting 60% and 54% increase in service coverage, respectively.
• Participated in the laboratory and field validation of the LAG HIV incidence test, a critically needed tool for surveillance of new HIV infections and associated risk factors.
• Co-authored manuscripts and press releases to communicate PEPFAR-BD PPP impact.
● • Supported evaluation of Early Infant Diagnosis programs in Cameroon and Uganda, drafting of evaluation protocols in collaboration with CDC Atlanta staff and PEPFAR in-country teams, and performed data analysis, reporting 60% and 54% increase in service coverage, respectively.
• Participated in the laboratory and field validation of the LAG HIV incidence test, a critically needed tool for surveillance of new HIV infections and associated risk factors.
• Co-authored manuscripts and press releases to communicate PEPFAR-BD PPP impact.
Connecticut Department of Public Health
Management Consulting
Mitigation & Economy Recovery Advisor
3/2021 - 9/2021
• Developed ~$53M vaccine equity strategy to guide state investments in an equitable COVID-19 response, awarding contracts to 27 local health departments and 109 CBOs.
• Managed stakeholder partnerships to enhance vaccine access for vulnerable communities.
• Advised on reimbursement strategies for the uninsured under HHS/HRSA Bridge Access Program.
• Led strategy, budgets, and contracts/grants workstreams, overseeing three vaccine equity consultants.
• Managed stakeholder partnerships to enhance vaccine access for vulnerable communities.
• Advised on reimbursement strategies for the uninsured under HHS/HRSA Bridge Access Program.
• Led strategy, budgets, and contracts/grants workstreams, overseeing three vaccine equity consultants.
Omega Diagnostics Group
Marketing
Senior Product Implementation Consultant
4/2015 - 10/2015
• Developed market access and reimbursement strategies for VISITECT CD4 Test, a disposable HIV staging diagnostic in countries supported by DOS/PEPFAR, Global Fund, UNAIDS, UNITAID, Clinton Health Initiative, etc., focusing on APAC and African Markets.
• Led collection of market data on regulatory frameworks, policy, and financing, distributor networks, to inform go-to-market strategies, focusing on national governments and international donor payors, to drive adoption in the target market's public sectors.
• Conducted health economic assessments and competitive research to support value-based pricing and post market surveillance, to ensure sustained product quality, access, and use.
• Established regional and in-country support structures for product sales and field services.
● US CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
• Led collection of market data on regulatory frameworks, policy, and financing, distributor networks, to inform go-to-market strategies, focusing on national governments and international donor payors, to drive adoption in the target market's public sectors.
• Conducted health economic assessments and competitive research to support value-based pricing and post market surveillance, to ensure sustained product quality, access, and use.
• Established regional and in-country support structures for product sales and field services.
● US CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
US CDC
Management Consulting
Health Systems Specialist
5/2013 - 8/2014
• Managed a $20m US PEPFAR and Becton, Dickinson PPP to strengthen health systems across Africa and APAC countries for HIV/AIDS, Tuberculosis, Malaria, and other HIV co-infections.
• Developed stakeholder management strategies for program execution across host Ministries of Health, US CDC, DOS/PEPFAR, BD, medical societies, and patient groups.
• Recommended evidence-based programs for intervention to host governments, and co-authored scientific manuscripts and press releases, to enhance program visibility.
• Developed budgeted annual work plans and managed a $500K task order for a federal contractor for program monitoring and evaluation.
• Developed stakeholder management strategies for program execution across host Ministries of Health, US CDC, DOS/PEPFAR, BD, medical societies, and patient groups.
• Recommended evidence-based programs for intervention to host governments, and co-authored scientific manuscripts and press releases, to enhance program visibility.
• Developed budgeted annual work plans and managed a $500K task order for a federal contractor for program monitoring and evaluation.
US CDC
Research
C. Program Officer
1/2010 - 8/2011
• Contributed to ~$350M DOS/PEPFAR Country Operation Plan development, guiding the USG annual investment, and oversaw $50M funding awards(13) for health services and medical commodity supply chains.
• Served on objective review panels for DOS/PEPFAR funding applications from several African countries.
• Served on Ministry of Health (MOH) taskforces for the inaugural National Health Laboratory Services Strategy
● and updated the National HIV Response Strategy ), and provided technical assistance for the establishment of the MOH Department for Laboratory Services.
• Served on the MOH taskforce for UNITAID International Drug Purchase Facility and the Affordable Medicines Facility malaria (AMFm), a private sector financing mechanism for Malaria artemisinin-based combination therapies, to accelerate access to high-quality diagnostics and drugs for HIV/AIDS, tuberculosis, and malaria.
• Served on objective review panels for DOS/PEPFAR funding applications from several African countries.
• Served on Ministry of Health (MOH) taskforces for the inaugural National Health Laboratory Services Strategy
● and updated the National HIV Response Strategy ), and provided technical assistance for the establishment of the MOH Department for Laboratory Services.
• Served on the MOH taskforce for UNITAID International Drug Purchase Facility and the Affordable Medicines Facility malaria (AMFm), a private sector financing mechanism for Malaria artemisinin-based combination therapies, to accelerate access to high-quality diagnostics and drugs for HIV/AIDS, tuberculosis, and malaria.
US CDC
Research
D. Quality Assurance Officer/Lab Technologist
3/2003 - 12/2009
• Served on the MOH task force for the National Health Laboratory Quality Master Plan for certification and accreditation across 2000+ laboratories.
• Conducted service gap analysis for laboratory services supporting HIV treatment programs.
• Managed Uganda National External Quality Assessment Scheme for HIV treatment monitoring tests.
• Recommended point-of-care diagnostics for inclusion on the National laboratory equipment essential list, in collaboration with regulatory authorities and international donors.
• Co-managed US PEPFAR/BD PPP for Laboratory systems strengthening and rolled out the national laboratory specimen referral system for MDR TB and pediatric DNA PCR testing, for centralized laboratory testing, with the Clinton Health Access Initiative, and others, reducing turnaround time by 40%.
• Implemented the national quality management training for laboratory staff and postal workers supporting the specimen referral system.
• Conducted service gap analysis for laboratory services supporting HIV treatment programs.
• Managed Uganda National External Quality Assessment Scheme for HIV treatment monitoring tests.
• Recommended point-of-care diagnostics for inclusion on the National laboratory equipment essential list, in collaboration with regulatory authorities and international donors.
• Co-managed US PEPFAR/BD PPP for Laboratory systems strengthening and rolled out the national laboratory specimen referral system for MDR TB and pediatric DNA PCR testing, for centralized laboratory testing, with the Clinton Health Access Initiative, and others, reducing turnaround time by 40%.
• Implemented the national quality management training for laboratory staff and postal workers supporting the specimen referral system.